Hepatitis C virus (HCV) hypervariable region 1 complexity does not correlate with severity of liver disease, HCV type, viral load or duration of infection

Journal of Hepatology

Volumn 29, Issue 5, 1998, Pages 689-694

  Leone, Francesco ^a   Zylberberg, Herve' ^b   Squadrito, Giovanni ^a   Le Guen, Bernard ^a   Berthelot, Pierre ^b   Pol, Stanislas ^b   Brechot, Christian ^a,b  

^a INSERM   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

HCV quasispecies; Knodell's grading; PCR SSCP analysis

Indexed keywords

AMINOTRANSFERASE; INTERFERON;

ARTICLE; CORRELATION FUNCTION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; VIRUS GENOME; VIRUS LOAD;

EID: 16744364557     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80247-X     Document Type: Article

References (36)

1. Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol. 66:1992;3225-3229.
2. Kurosaki M, Enomoto N, Marumo F, Sato C. Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C. Virology. 205:1994;161-169.
3. Sekiya H, Kato N, Ootsuyama Y, Nakazawa T, Yamauchi K, Shimotohno K. Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: humoral immune response to hypervariable region 1. Int J Cancer. 57:1994;664-670.
4. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis. 15:1995;41-63.
5. Simmonds P. Viriability of hepatitis C virus. Hepatology. 21:1995;570-583.
6. Brechot C. Hepatitis C virus: molecular biology and genetic variability. Dig Dis Sci. 41:1996;6S-21S. (Suppl).
7. Enomoto N, Kurosaki M, Tanaka Y, Marumo F, Sato C. Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis. J Gen Virol. 75:1994;1361-1369.
8. Moribe T, Hayashi N, Kanazawa Y, Mita E, Fusamoto H, Negi M, et al. Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy. Gastroenterology. 108:1995;789-795.
9. Koizumi K, Enomoto N, Kurosaki M, Murakami T, Izumi N, Marumo F, et al. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology. 22:1995;30-35.
10. Le Guen B, Squadrito G, Nalpas B, Berthelot P, Pol S, Brechot C. Heptitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C. Hepatology. 25:1997;1250-1254.
11. Toyoda H, Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, et al. Quasispecies nature of hepatitis C virus and response to alpha interferon: significance as a predictor of direct response to interferon. J Hepatol. 26:1997;6-13.
12. Polyak SJ, Faulkner G, Carithers RL Jr, Corey L, Gretch DR. Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: correlation with response to interferon therapy. J Infect Dis. 175:1997;1101-1107.
13. Honda M, Kaneko S, Sakai A, Unoura M, Murakami S, Kobayashi K. Degree of diversity of hepatitis C virus quasi-species and progression of liver disease. Hepatology. 20:1994;1144-1151.
14. Hayashi J, Kishihara Y, Yamaji K, Furusyo N, Yamamoto T, Pae Y, et al. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection. Hepatology. 25:1997;697-701.
15. Naito M, Hayashi N, Moribe T, Hagiwara H, Mita E, Kanazawa Y, et al. Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease. Hepatology. 22:1995;407-412.
16. Naito M, Hayashi N, Hagiwara H, Hiramatsu N, Kasahara A, Fusamoto H, et al. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. Hepatology. 19:1994;871-875.
17. Prieto M, Olaso V, Verdù C, Cordoba J, Gisbert C, Rayon M, et al. Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction. Hepatology. 22:1995;413-417.
18. Smith DB, McAllister J, Casino C, Simmonds P. Virus "quasispecies": making a mountain out of molehill? J Gen Virol. 78:1997;1511-1519.
19. Knodell KG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numeric scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
20. Giannini C, Thiers V, Nousbaum JB, Stuyver K, Maertens G, Brechot C. Comparative analysis of two assays for genotyping hepatitis C virus (HCV) based on type specific primers or type specific probes. J Hepatol. 23:1995;246-253.
21. Thiers V, Jaffredo F, Tuveri R, Chodan N, Brechot C. Development of a simple restriction fragment length polymorphism (RFLP) based assay for HCV genotyping and comparative analysis with genotyping and serotyping tests. J Virol Methods. 65:1997;9-17.
22. De Mitri MS, Poussin K, Baccarini P, Pontisso P, D'Errico A, Simon N, et al. HCV-associated liver cancer without cirrhosis. Lancet. 345:1995;413-415.
23. Zylberberg H, Pol S, Nalpas B, Brechot C, Berthelot P. Significance of repeatedly normal aminotransferase activities in hepatitis C virus-infected patients [letter]. Hepatology. 27:1998;1169.
24. Nowak MA, May RM, Anderson RM. The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease. AIDS. 4:1990;1095-1103.
25. Cichutek K, Merget H, Norley S, Linde R, Kreuz W, Gahr M, et al. Development of a quasispecies of human immunodeficiency virus type 1 in vivo. Proc Natl Acad Sci USA. 89:1992;7365-7369.
26. Simmonds P, Balfe P, Ludlam CA, Bishop JO, Brown AJ. Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. J Virol. 64:1990;5840-5850.
27. Coffin JM. HIV population dynamics in vivo: implication for genetic variation, pathogenesis, and therapy. Science. 267:1995;483-489.
28. Coffin JM. HIV viral dynamics. AIDS. 10:1996;S75-S88. (Suppl).
29. Lukashow V, Kuiken C, Goudsmit J. Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period. J Virol. 69:1995;6911-6916.
30. Wolfs TF, de Jong JJ, Van den Berg H, Tijnagel JM, Krone WJ, Goudsmit J. Evolution of sequence encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid, and continuous. Proc Natl Acad Sci USA. 87:1990;9938-9942.
31. Delwart EL, Pan H, Sheppard HW, Wolpert D, Neumann AU, Korber B, et al. Slower evolution of human immunodeficiency type 1 quasispecies during progression to AIDS. J Virol. 71:1997;7498-7508.
32. McNearney T, Hornickova Z, Markham R, Birdwell A, Arens M, Saah A, et al. Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. Proc Natl Acad Sci USA. 89:1992;10242-10251.
33. Alberti A, Morisca G, Chemello L, Cavalletto D, Noventa F, Pontisso P, et al. Hepatitis C viremia and liver disease in symptom-free individuals with anti-HCV. Lancet. 340:1992;697-698.
34. Yuki N, Hayashi N, Moribe T, Matsushita Y, Tabata T, Inoue T, et al. Relation of disease activity during chronic hepatitis C infection to complexity of hypervariable region 1 quasispecies. Hepatology. 25:1997;439-444.
35. Brillianti S, Foli M, Gaiani S, Masci C, Miglioli M, Barbara L. Persistent hepatitis C viremia without liver disease. Lancet. 341:1993;464-465.
36. Brambilla S, Bellati G, Asti M, Lisa A, Candusso ME, D'Amico M, et al. Dynamics of hypervariable region 1 variation in hepatitis C virus infection and correlation with clinical and virological features of liver disease. Hepatology. 26:1998;1678-1686.